NMDA receptor (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "NMDA receptor" in Czech language version.

refsWebsite
Global rank Czech rank
2nd place
4th place
4th place
8th place
234th place
72nd place
6,663rd place
4,114th place
610th place
203rd place

aspetjournals.org

pharmrev.aspetjournals.org

  • Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol. Rev.. March 1999, s. 7–61. Dostupné online. PMID 10049997. 

doi.org

dx.doi.org

  • Laube B, Hirai H, Sturgess M, Betz H, Kuhse J. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron. 1997, s. 493–503. DOI 10.1016/S0896-6273(00)81249-0. PMID 9115742. 
  • FURUKAWA, Hiroyasu; SINGH, Satinder K; MANCUSSO1, Romina; GOUAUX, Eric. Subunit arrangement and function in NMDA receptors. Nature. November 2005, s. 185–92. DOI 10.1038/nature04089. PMID 16281028. 
  • Li F, Tsien JZ. Memory and the NMDA receptors. N. Engl. J. Med.. 2009, s. 302–3. DOI 10.1056/NEJMcibr0902052. PMID 19605837. 
  • Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor.. Nature. November 1991, s. 31–37. Dostupné online. DOI 10.1038/354031a0. PMID 1834949. 
  • Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol.. June 2001, s. 327–35. Dostupné online. DOI 10.1016/S0959-4388(00)00215-4. PMID 11399431. 
  • Paoletti P, Neyton J. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol. February 2007, s. 39–47. DOI 10.1016/j.coph.2006.08.011. PMID 17088105. 
  • Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science. August 1988, s. 835–7. DOI 10.1126/science.2841759. PMID 2841759. 
  • Johnson J.W., Kotermanski S.E. Mechanism of action of memantine. Current Opinion in Pharmacology. 2006, s. 61–67. DOI 10.1016/j.coph.2005.09.007. 
  • DOMINGUEZ, Evangelyn; CHIN, Ting-Yu; CHEN, Chih-Ping; WU, Tzong-Yuan. Management of moderate to severe Alzheimer's disease: Focus on memantine. Taiwanese Journal of Obstetrics and Gynecology. December 2011, s. 415–423. DOI 10.1016/j.tjog.2011.10.004. 
  • CHEN, Huei-Sheng Vincent; LIPTON, Stuart A. The chemical biology of clinically tolerated NMDA receptor antagonists. Journal of Neurochemistry. June 2006, s. 1611–1626. DOI 10.1111/j.1471-4159.2006.03991.x. PMID 16805772. 
  • Kemp J. A., McKernan R. M. NMDA receptor pathways as drug targets. Nature Neuroscience. 2002, s. 1039–1042. DOI 10.1038/nn936. 
  • Lipton S.A. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nature Reviews Drug Discovery. 2006, s. 160–170. DOI 10.1038/nrd1958. PMID 16424917. 
  • KOCH, Horst; SZECSEY, Alexander; HAEN, Ekkehard. NMDA-antagonism (Memantine): An Alternative Pharmacological Therapeutic Principle in Alzheimers and Vascular Dementia. Current Pharmaceutical Design. 1 January 2004, s. 253–259. DOI 10.2174/1381612043386392. 
  • STEULLET, P; NEIJT, H.C; CUÉNOD, M; DO, K.Q. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia. Neuroscience. 2006, s. 807–19. DOI 10.1016/j.neuroscience.2005.10.014. PMID 16330153. 
  • LIPTON, Stuart A. Failures and successes of NMDA receptor antagonists: Molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx. January 2004, s. 101–110. DOI 10.1602/neurorx.1.1.101. PMID 15717010. 
  • FURUKAWA, Hiroyasu; SINGH, Satinder K; MANCUSSO, Romina; GOUAUX, Eric. Subunit arrangement and function in NMDA receptors. Nature. 10 November 2005, s. 185–192. DOI 10.1038/nature04089. PMID 16281028. 
  • Loftis J. M., Janowsky A. The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther. 2003, s. 55–85. DOI 10.1016/s0163-7258(02)00302-9. PMID 12493535. 
  • KRISTIANSEN, Lars V; HUERTA, Ibone; BENEYTO, Monica; MEADOR-WOODRUFF, James H. NMDA receptors and schizophrenia. Current Opinion in Pharmacology. February 2007, s. 48–55. DOI 10.1016/j.coph.2006.08.013. PMID 17097347. 
  • LIMAPICHAT, Walrati; YU, Wesley Y.; BRANIGAN, Emma; LESTER, Henry A.; DOUGHERTY, Dennis A. Key Binding Interactions for Memantine in the NMDA Receptor. ACS Chemical Neuroscience. 20 February 2013, s. 255–260. DOI 10.1021/cn300180a. 

elsevier.com

linkinghub.elsevier.com

nature.com

  • Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor.. Nature. November 1991, s. 31–37. Dostupné online. DOI 10.1038/354031a0. PMID 1834949. 

nih.gov

ncbi.nlm.nih.gov

  • Laube B, Hirai H, Sturgess M, Betz H, Kuhse J. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron. 1997, s. 493–503. DOI 10.1016/S0896-6273(00)81249-0. PMID 9115742. 
  • FURUKAWA, Hiroyasu; SINGH, Satinder K; MANCUSSO1, Romina; GOUAUX, Eric. Subunit arrangement and function in NMDA receptors. Nature. November 2005, s. 185–92. DOI 10.1038/nature04089. PMID 16281028. 
  • Li F, Tsien JZ. Memory and the NMDA receptors. N. Engl. J. Med.. 2009, s. 302–3. DOI 10.1056/NEJMcibr0902052. PMID 19605837. 
  • Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor.. Nature. November 1991, s. 31–37. Dostupné online. DOI 10.1038/354031a0. PMID 1834949. 
  • Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol. Rev.. March 1999, s. 7–61. Dostupné online. PMID 10049997. 
  • Liu; ZHANG, J. Recent development in NMDA receptors. Chinese medical journal. 2000, s. 948–56. PMID 11775847. 
  • Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol.. June 2001, s. 327–35. Dostupné online. DOI 10.1016/S0959-4388(00)00215-4. PMID 11399431. 
  • Paoletti P, Neyton J. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol. February 2007, s. 39–47. DOI 10.1016/j.coph.2006.08.011. PMID 17088105. 
  • Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science. August 1988, s. 835–7. DOI 10.1126/science.2841759. PMID 2841759. 
  • CHEN, Huei-Sheng Vincent; LIPTON, Stuart A. The chemical biology of clinically tolerated NMDA receptor antagonists. Journal of Neurochemistry. June 2006, s. 1611–1626. DOI 10.1111/j.1471-4159.2006.03991.x. PMID 16805772. 
  • Lipton S.A. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nature Reviews Drug Discovery. 2006, s. 160–170. DOI 10.1038/nrd1958. PMID 16424917. 
  • STEULLET, P; NEIJT, H.C; CUÉNOD, M; DO, K.Q. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia. Neuroscience. 2006, s. 807–19. DOI 10.1016/j.neuroscience.2005.10.014. PMID 16330153. 
  • LIPTON, Stuart A. Failures and successes of NMDA receptor antagonists: Molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx. January 2004, s. 101–110. DOI 10.1602/neurorx.1.1.101. PMID 15717010. 
  • FURUKAWA, Hiroyasu; SINGH, Satinder K; MANCUSSO, Romina; GOUAUX, Eric. Subunit arrangement and function in NMDA receptors. Nature. 10 November 2005, s. 185–192. DOI 10.1038/nature04089. PMID 16281028. 
  • Loftis J. M., Janowsky A. The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther. 2003, s. 55–85. DOI 10.1016/s0163-7258(02)00302-9. PMID 12493535. 
  • KRISTIANSEN, Lars V; HUERTA, Ibone; BENEYTO, Monica; MEADOR-WOODRUFF, James H. NMDA receptors and schizophrenia. Current Opinion in Pharmacology. February 2007, s. 48–55. DOI 10.1016/j.coph.2006.08.013. PMID 17097347.